MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1744666x.2016.1218761

Медицинская библиотека · Expert review of clinical immunology · 2016

An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.

Osman Mohammed S, Maksymowych Walter P

СтатьяОбзорПеревод в очереди

Аннотация

Ankylosing spondylitis is a chronic immune-mediated disease affecting the sacroiliac joints and the spine manifesting with new bone formation and osteopenia. Over the past decade, tumour necrosis factor alpha (TNF-α) inhibitors (TNFi) have become the cornerstone for therapy in improving functional outcomes, and decreasing disease activity in patients with a marginal benefit from non-steroidal anti-inflammatory (NSAID) therapy. At this time, it remains to be determined whether these agents decrease new bone formation, although some studies have recently suggested that. Areas covered: In this review we discuss the factors that favour a good response to these agents both initially and during maintenance, and some of the more recent studies outlining strategies for dose reduction. Expert commentary: Finally, we discuss the importance of using more objective tools for disease activity, such as magnetic resonance imaging, as a complementary tool for clinical assessments in both predicting responses to treatment but also in selecting patients most suited for targeted therapy.

Для цитирования: Osman Mohammed S, Maksymowych Walter P. An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.. Expert review of clinical immunology. 2016. DOI: 10.1080/1744666x.2016.1218761.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.